250 related articles for article (PubMed ID: 20400196)
1. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials.
Lamers MM; van Oijen MG; Pronk M; Drenth JP
J Hepatol; 2010 Jul; 53(1):191-8. PubMed ID: 20400196
[TBL] [Abstract][Full Text] [Related]
2. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.
Pape S; Gevers TJG; Belias M; Mustafajev IF; Vrolijk JM; van Hoek B; Bouma G; van Nieuwkerk CMJ; Hartl J; Schramm C; Lohse AW; Taubert R; Jaeckel E; Manns MP; Papp M; Stickel F; Heneghan MA; Drenth JPH
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2068-2075.e2. PubMed ID: 30625402
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Banerjee S; Rahhal R; Bishop WP
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
McNally BB; Carey EJ
Dig Dis Sci; 2021 May; 66(5):1715-1719. PubMed ID: 32436124
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for autoimmune hepatitis.
Manns MP; Strassburg CP
Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
[TBL] [Abstract][Full Text] [Related]
6. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Pediatric Autoimmune Hepatitis and Significance of Azathioprine Metabolites.
Sheiko MA; Sundaram SS; Capocelli KE; Pan Z; McCoy AM; Mack CL
J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):80-85. PubMed ID: 28272159
[TBL] [Abstract][Full Text] [Related]
8. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM; Stoelinga AEC; Gevers TJG; Pape S; Biewenga M; Tushuizen ME; Verdonk RC; de Jonge HJM; Vrolijk JM; Bakker SF; Vanwolleghem T; de Boer YS; Baven Pronk MAMC; Beuers U; van der Meer AJ; Gerven NMFV; Sijtsma MGM; van Eijck BC; van IJzendoorn MC; van Herwaarden M; van den Brand FF; Korkmaz KS; van den Berg AP; Guichelaar MMJ; Levens AD; van Hoek B; Drenth JPH;
J Hepatol; 2024 Apr; 80(4):576-585. PubMed ID: 38101756
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.
Binicier OB; Günay S
Croat Med J; 2019 Aug; 60(4):345-351. PubMed ID: 31483120
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
Palace J; Newsom-Davis J; Lecky B
Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of azathioprine monotherapy for maintenance treatment of autoimmune hepatitis in children.
Aksoy B; Baran M; Cagan Appak Y; Sag E; Cakir M; Guven B; Yavuz S; Emir B; Tumgor G
Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):92-97. PubMed ID: 32956178
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Hepatitis in Children: Prednisone Plus Azathioprine Versus Cyclosporine: A Randomized Trial.
Cuarterolo ML; Ciocca M; López S; Araujo M; Álvarez F
J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):376-380. PubMed ID: 32520828
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L
Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741
[TBL] [Abstract][Full Text] [Related]
14. Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?
Harrison L; Gleeson D
Liver Int; 2019 Apr; 39(4):610-620. PubMed ID: 30667576
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune hepatitis treatment in the elderly: A systematic review.
Durazzo M; Lupi G; Scandella M; Ferro A; Gruden G
World J Gastroenterol; 2019 Jun; 25(22):2809-2818. PubMed ID: 31236003
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.
Rizvi S; Gawrieh S
Drugs Aging; 2018 Jul; 35(7):589-602. PubMed ID: 29971609
[TBL] [Abstract][Full Text] [Related]
18. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hepatitis: Current and future therapeutic options.
Doycheva I; Watt KD; Gulamhusein AF
Liver Int; 2019 Jun; 39(6):1002-1013. PubMed ID: 30716203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
